glycidyl nitrate has been researched along with Intestinal Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Addabbo, F; Bettini, S; Cavalcanti, E; Chieppa, M; Delvecchio, FR; Huang, AY; Liou, R; MonsurrĂ², V; Pizarro, TT; Santino, A; Vadrucci, E | 1 |
Cao, J; Chen, Q; Cui, F; Gu, YP; Liu, W; Wu, A; Wu, S; Xia, X; Zhang, X | 1 |
Kawachi, K; Nakagawa, H; Nakata, T; Tsunooka, N; Yamamoto, Y; Yoshida, M | 1 |
Adam, AA; Colman, RW; Janardham, R; Kettner, CA; Majluf-Cruz, A; Sartor, RB; Stadnicki, A | 1 |
4 other study(ies) available for glycidyl nitrate and Intestinal Diseases
Article | Year |
---|---|
Administration of reconstituted polyphenol oil bodies efficiently suppresses dendritic cell inflammatory pathways and acute intestinal inflammation.
Topics: Acute Disease; Alkaloids; Animals; Benzodioxoles; Capsules; Colitis; Dendritic Cells; Dextran Sulfate; Dose-Response Relationship, Drug; Drug Stability; Inflammation; Interleukin-6; Intestinal Diseases; Lipopolysaccharides; Liposomes; Mice; Peptidoglycan; Piperidines; Polyphenols; Polyunsaturated Alkamides; Quercetin; Tumor Necrosis Factor-alpha | 2014 |
Radioprotector WR-2721 and mitigating peptidoglycan synergistically promote mouse survival through the amelioration of intestinal and bone marrow damage.
Topics: Amifostine; Animals; Bone Marrow Diseases; Drug Synergism; Intestinal Diseases; Male; Mice; Mice, Inbred C57BL; Peptidoglycan; Radiation Injuries; Radiation-Protective Agents; Survival Rate; Treatment Outcome | 2015 |
Pitavastatin prevents intestinal ischemia/reperfusion-induced bacterial translocation and lung injury in atherosclerotic rats with hypoadiponectinemia.
Topics: Adiponectin; Animals; Atherosclerosis; Bacterial Translocation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Diseases; Lung Injury; Male; Nitric Oxide; Peptidoglycan; Quinolines; Rats; Rats, Wistar; Reperfusion Injury | 2009 |
Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible rats.
Topics: Acute-Phase Proteins; Animals; Arthritis; Boron Compounds; Disease Models, Animal; Disease Susceptibility; Enzyme Inhibitors; Factor XI; Female; Granulomatous Disease, Chronic; Humans; Inflammation; Intestinal Diseases; Kallikreins; Kininogens; Oligopeptides; Peptidoglycan; Prekallikrein; Rats; Rats, Inbred Lew | 1998 |